The National Institutes of Health (NIH) has awarded a research grant to Thomas Weimbs for the proposal titled "A Novel Role of Syntaxin 3 as a Transcription Regulator". This is a 2-year Exploratory/Developmental Research Grant Award (R21). The total award for the first year is $219,525.